一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-cell sequencing on CD8(+) TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer.
Single-cell sequencing on CD8(+) TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们聚焦于 CD8+ TIL 中具有耗竭表型的 T 细胞的方法,可能有助于鉴定肿瘤抗原,并阐明抗原特异性 T 细胞的性质,从而为 NSCLC 患者确定有前景的免疫治疗靶点。
CD8+ TIL(肿瘤浸润淋巴细胞)(TILs)常见于非小细胞肺癌(NSCLC)中。然而,CD8+ TILs 的特征,尤其是针对肿瘤抗原特异性的 T 细胞群体,仍知之甚少。
对3例手术切除的肺癌标本中的CD8+ TIL进行了高通量单细胞RNA测序和单细胞T细胞受体(TCR)测序。使用Uniform Manifold Approximation and Projection进行降维聚类。研究了针对癌症/睾丸抗原KK-LC-1和预测新抗原的特异性CD8+ TIL TCR。通过差异表达基因分析、基因集富集分析(GSEA)和单样本GSEA来表征抗原特异性T细胞。
共分析6998个CD8+ T细胞,根据其基因表达谱分为10个簇。鉴定出一个耗竭T细胞(exhausted T,Tex)簇,其特征为表达ENTPD1(CD39)、TOX、PDCD1(PD1)、HAVCR2(TIM3)等基因,并具有T细胞寡克隆性。Tex TCR库(Tex-TCRs)包含9种不同的TCR克隆型,识别5种肿瘤抗原,包括一种KK-LC-1抗原和四种新抗原。通过对肿瘤抗原特异性T细胞(n=140)重新聚类可见,即使在同一个Tex簇内,单个T细胞克隆型也存在于不同分化阶段和功能状态的细胞上。用预测的同源肽刺激这些T细胞表明,TCR信号强度及随后的T细胞增殖和细胞因子产生是可变的,但新抗原始终高于KK-LC-1。
CD8 + tumor infiltrating lymphocytes (TILs) are often observed in non-small cell lung cancers (NSCLC). However, the characteristics of CD8 + TILs, especially T-cell populations specific for tumor antigens, remain poorly understood.
High throughput single-cell RNA sequencing and single-cell T-cell receptor (TCR) sequencing were performed on CD8 + TILs from three surgically-resected lung cancer specimens. Dimensional reduction for clustering was performed using Uniform Manifold Approximation and Projection. CD8 + TIL TCR specific for the cancer/testis antigen KK-LC-1 and for predicted neoantigens were investigated. Differentially-expressed gene analysis, Gene Set Enrichment Analysis (GSEA) and single sample GSEA was performed to characterize antigen-specific T cells.
A total of 6998 CD8 + T cells was analyzed, divided into 10 clusters according to their gene expression profile. An exhausted T-cell (exhausted T (Tex)) cluster characterized by the expression of ENTPD1 (CD39), TOX , PDCD1 (PD1), HAVCR2 (TIM3) and other genes, and by T-cell oligoclonality, was identified. The Tex TCR repertoire (Tex-TCRs) contained nine different TCR clonotypes recognizing five tumor antigens including a KK-LC-1 antigen and four neoantigens. By re-clustering the tumor antigen-specific T cells (n=140), it could be seen that the individual T-cell clonotypes were present on cells at different stages of differentiation and functional states even within the same Tex cluster. Stimulating these T cells with predicted cognate peptide indicated that TCR signal strength and subsequent T-cell proliferation and cytokine production was variable but always higher for neoantigens than KK-LC-1.
Our approach focusing on T cells with an exhausted phenotype among CD8 + TILs may facilitate the identification of tumor antigens and clarify the nature of the antigen-specific T cells to specify the promising immunotherapeutic targets in patients with NSCLC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。